Related Experiment Videos

Effects of upper-extremity vascular access creation on cardiac events in patients undergoing coronary artery bypass

Youngjin Han1, Suk Jung Choo2, Hyunwook Kwon1

  • 1Department of and Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea.

Plos One
|September 6, 2017
PubMed

Insights

Creating upper-extremity vascular access (VA) before coronary artery bypass grafting (CABG) with a left internal thoracic artery (ITA) graft does not increase major adverse cardiac events (MACE) or death. However, the type of VA, specifically prosthetic arteriovenous grafting, is a significant predictor of MACE or death.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Interventional Cardiology

Background:

  • Coronary artery bypass grafting (CABG) with a left internal thoracic artery (ITA) graft is a standard procedure.
  • Upper-extremity vascular access (VA) is frequently created in patients undergoing CABG.
  • The potential impact of VA creation on cardiac outcomes in this specific patient population remains unclear.

Purpose of the Study:

  • To investigate whether upper-extremity VA creation increases the risk of major adverse cardiac events (MACE) and death in patients undergoing CABG with an in situ left ITA graft.
  • To determine if the side (ipsilateral vs. contralateral) or type of VA influences these outcomes.

Main Methods:

  • Retrospective analysis of 111 patients who underwent CABG with a left ITA graft and subsequent upper-extremity VA creation.
  • Patients were categorized into ipsilateral (left-sided VA) and contralateral (right-sided VA) groups.
  • Outcomes assessed included MACE and the composite of MACE or late death, analyzed using multivariate regression.

Main Results:

  • No significant difference in MACE or MACE/late death was observed between ipsilateral and contralateral VA groups.
  • Prior cerebrovascular accidents and VA type were independently associated with MACE.
  • Prior peripheral arterial occlusive disease and prosthetic arteriovenous grafting were associated with MACE or death.

Conclusions:

  • Ipsilateral upper-extremity VA creation does not appear to increase the risk of MACE or late death in patients undergoing CABG with a left ITA graft.
  • The type of VA, particularly prosthetic arteriovenous grafting, is a significant predictor of adverse cardiac events and mortality.
  • Further research may be warranted to explore the implications of different VA types in this patient cohort.

Related Concept Videos